ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1021

Magnetic Resonance Imaging in Follow-up of Clinical Remission in Juvenile Idiopathic Arthritis

Mira van Veenendaal1, Robert Hemke2, Marjolein I. Bos3, Mario Maas4, Marion A. J. Van Rossum3 and Taco W. Kuijpers5, 1Departments of Pediatric Rheumatology, Emma Children's Hospital / Academic Medical Center (AMC), Amsterdam, Netherlands, 2Departments of Radiology, Academic Medical Center (AMC), Amsterdam, Netherlands, 3Department of Pediatric Rheumatology and Immunology, Emma Children's Hospital / Academic Medical Center (AMC), Amsterdam, Netherlands, 4Radiology, Academic Medical Center, Amsterdam, Netherlands, 5Pediatric Rheumatology and Immunology, Emma Children's Hospital/Academic Medical Center (AMC), Amsterdam, Netherlands

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: imaging techniques, juvenile idiopathic arthritis (JIA), pediatric rheumatology and remission

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Imaging of Rheumatic Diseases: Magnetic Resonance Imaging, Computed Tomography and X-ray

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Despite clinical remission, a substantial proportion of Juvenile Idiopathic Arthritis (JIA) patients will flare after a period of inactive disease. MRI has proven to depict subclinical inflammation as reflected by synovial hypertrophy, and may therefore be useful to identify patients at risk for flaring during follow-up.    

The purpose of this study, focussing on the main target joint, was to use MRI in JIA patients in clinical remission, and to identify inflammatory changes as compared to clinical status over time.

Methods:

In this prospective study, 16 patients with JIA (median age 11.8 years [IQR, 10.5-14.5], median disease duration 3.2 years [IQR, 1.8-5.6]) in clinical remission (fulfilling the Pediatric Rheumatology International Trials Organization (PRINTO) preliminary criteria for clinical remission) were studied with MRI at 2 consecutive time points (median interval 16.1 months [IQR 14.4-17.1]) and assessed for clinical relapse. Initial clinical remission was achieved in 14 patients on medication (CRM) (median duration inactive disease 11.0 months [IQR 7.2-13.7]) and in 2 patients off medication (CR) (median duration inactive disease 28.7 months [IQR 15.7-28.7]). Contrast-enhanced MRI of the formerly most involved knee was performed to evaluate the degree of synovial hypertrophy, using the validated Juvenile Arthritis MRI Scoring (JAMRIS) (synovial hypertrophy score; <2 mm=0, 2-4 mm=1 and >4 mm=2, at 8 knee regions).

Results:

The first MRI showed signs of subclinical synovitis in 8 patients (50 %) and no synovitis in 8 patients. The second MRI in follow-up demonstrated an increased score of synovial hypertrophy as compared to the first MRI in the 6 patients with relapse of arthritis. In contrast, all patients with sustained clinical remission showed either stable (6 patients) or improved (4 patients) scores of synovial hypertrophy. CRP and erythrocyte sedimentation rate were not increased at both MRI time points.

Conclusion:

A large degree of JIA patients who satisfy the PRINTO remission criteria with normal findings on clinical and laboratory assessment had MRI based synovitis in this study, suggestive of ongoing disease activity. Increase of synovial hypertrophy over time was related to disease flaring, whereas stable or further reduction of synovial hypertrophy was associated with sustained clinical remission. Serial MRI allows for adequate follow-up of underlying disease even when clinically silent.


Disclosure:

M. van Veenendaal,
None;

R. Hemke,
None;

M. I. Bos,
None;

M. Maas,
None;

M. A. J. Van Rossum,
None;

T. W. Kuijpers,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/magnetic-resonance-imaging-in-follow-up-of-clinical-remission-in-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology